Pfizer’s 6.7% Dividend: Can It Survive Plunging Profits and Cash Flow Crunch? May 12, 2026 Life Science
Hantavirus Fears Fuel Moderna Rally: Is This a Real Catalyst or Just Sentiment? May 11, 2026 Life Science
Eli Lilly Stock Hits Bottleneck After 400% Surge in Five Years, Novo Nordisk Poised for a Comeback with 4% Dividend Yield May 8, 2026 Life Science
Two High-Yield Healthcare Stocks: Top Picks for Retirement Portfolios May 8, 2026 Life Science, Real Estate
Quarterly Sales Reach $8.7 Billion, Eli Lilly’s Mounjaro Becomes New Blockbuster Drug King May 6, 2026 Life Science
Stop Chasing Overvalued Tech: These 2 Underrated Growth Stocks Are Too Cheap To Ignore May 4, 2026 Life Science, Technology
Eli Lilly’s Alzheimer’s Drug Kisunla Wins Health Canada Approval, Bolstering Global Footprint May 4, 2026 Life Science
Stock Isn’t Cheap but Still Worth Buying? Three Hard Reasons Behind Eli Lilly Explained May 4, 2026 Life Science
Dark Horse in the Weight-Loss Drug Arena? Viking Therapeutics Has Potential Upside of Over 200% May 4, 2026 Life Science
Want to Build Real Wealth in the Healthcare Sector? These Stocks Are Worth Considering Apr 30, 2026 Life Science
Bristol Myers Squibb Beats on Q1 Sales, Profit; Stock Jumps 5% as Growth Portfolio Shines Apr 30, 2026 Life Science
Shorted-to-The-Hilt KalVista Rockets 39% as Chiesi Swoops in With $1.9bn Cash Bid Apr 29, 2026 Life Science
Up 33% Year-to-Date, the Overlooked Retail Dividend Stock Target Finds a Rebound Opportunity Apr 28, 2026 Consumer Goods
High-Yield Healthcare Plays: MPT and Pfizer Offer 7% and 6.4% Dividends as Markets Turn Choppy Apr 28, 2026 Life Science, Real Estate
From Weight Loss to Cancer Treatment Drugs, Eli Lilly Has More Than One Ace in the Hole Apr 28, 2026 Life Science
